Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any acute myeloid leukemia that has the chromosomal anomaly t(v;11q23.3). (A chromosomal abnormality consisting of the translocation of genetic material from any one of several chromosomes to the 11q23.3 region, resulting in an MLL gene rearrangement.)
Biomarker and diagnostic research for acute myeloid leukemia, t(v;11q23.3) has been reported in the published literature.
No clinical trials have been registered for acute myeloid leukemia, t(v;11q23.3).
6 publications have been identified in PubMed for acute myeloid leukemia, t(v;11q23.3). Kisho has analyzed 2 by research type. Research spans Diagnostic / Biomarker (100%).
Li S (2025). [PMID: 40425457](https://pubmed.ncbi.nlm.nih.gov/40425457/). *Zhonghua Xue Ye Xue Za Zhi*. [Diagnostic / Biomarker]
Hernández-Sánchez A (2024). [PMID: 38965370](https://pubmed.ncbi.nlm.nih.gov/38965370/). *Leukemia*. [Diagnostic / Biomarker]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 3:02 PM UTC
Common questions about acute myeloid leukemia, t(v;11q23.3)